FDA Lists Safety Concerns, Recommends Trials for Head Lice Treatments

Drug Industry Daily
A A
The FDA encouraged additional development in topical treatments for head lice infestation, especially in pediatric populations, due to the genetic resistance to the most common treatments.

To View This Article:

Login

Subscribe To Drug Industry Daily